| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9B | $4.2B | $5.3B | $4.2B | $1.0B | $0.9B | $1.0B | — |
| Cost of Revenue | — | — | $4.5B | $3.6B | $3.1B | $3.1B | $3.2B | — |
| Gross Profit | — | — | $0.9B | $0.6B | $0.1B | $0.1B | $0.1B | $0.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.1B | $0.2B | $0.5B | $0.2B | $0.0B | $0.0B | $0.0B | $0.0B |
| Net Income | $0.1B | $0.2B | $0.4B | $0.2B | $0.0B | $0.0B | $0.0B | $0.1B |
| EPS (Basic) | $1.72 | $2.65 | $10.75 | $5.13 | $0.67 | $0.85 | $1.46 | $3.01 |
| EPS (Diluted) | $1.70 | $2.62 | $10.64 | $5.06 | $0.67 | $0.84 | $1.46 | $2.99 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.9B | $2.9B | $2.8B | $2.4B | $2.1B | $2.0B | $1.9B | $1.7B |
| Current Assets | $0.8B | $0.8B | $1.1B | $0.9B | $0.7B | $0.6B | $0.6B | $0.7B |
| Cash & Equivalents | $0.1B | $0.2B | $0.3B | $0.2B | $0.1B | $0.2B | $0.1B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.6B | $0.7B | $0.7B | $0.7B | $0.5B | $0.5B | $0.5B | $0.5B |
| Stockholders' Equity | $1.6B | $1.6B | $1.6B | $1.3B | $1.2B | $1.1B | $1.0B | $0.8B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.4B | $0.5B | $0.3B | $0.2B | $0.3B | $0.2B | — |
| Investing Cash Flow | $-0.1B | $-0.4B | $-0.3B | $-0.2B | $-0.2B | $-0.1B | $-0.2B | — |
| Capital Expenditures | $0.1B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B | $0.2B | $0.1B |
| Financing Cash Flow | $-0.2B | $-0.1B | $-0.1B | $-0.0B | $-0.0B | $-0.1B | $0.0B | — |